Sun Bulkactives Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-05-2024
- Paid Up Capital ₹ 0.50 M
as on 15-05-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1656.92%
(FY 2022)
- Profit 12.10%
(FY 2022)
- Ebitda 12.66%
(FY 2022)
- Net Worth -690.20%
(FY 2022)
- Total Assets -1.55%
(FY 2022)
About Sun Bulkactives
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Akansha Pilani and Ranju Pilani serve as directors at the Company.
- CIN/LLPIN
U24232MH2007PTC173156
- Company No.
173156
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sun Bulkactives Private Limited offer?
Sun Bulkactives Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Chemical Reagents & Catalysts, Inorganic Salts, Common Disease Medicines, Pharmaceutical Medicine, Ointment, Flavours & Aromatics, Food Stabilizer, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Sun Bulkactives?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akansha Pilani  | Director | 16-Aug-2007 | Current |
| Ranju Pilani | Director | 16-Aug-2007 | Current |
Financial Performance and Corporate Structure Insights of Sun Bulkactives.
Sun Bulkactives Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1656.92% increase. The company also saw a substantial improvement in profitability, with a 12.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 690.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sun Bulkactives?
In 2021, Sun Bulkactives had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
United Biochemicals Private LimitedActive 19 years 5 monthsAkansha Pilani and Ranju Pilani are mutual person
Agarwal Life Sciences Private LimitedActive 14 years 11 monthsAkansha Pilani and Ranju Pilani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sun Bulkactives?
Unlock and access historical data on people associated with Sun Bulkactives, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Bulkactives, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Bulkactives's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
